25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

TVGN (Tevogen) Stock Analysis
Buy, Hold or Sell?

Let's analyze Tevogen together

I guess you are interested in Tevogen Bio Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • 📊 Fundamental Analysis (FA) – Tevogen’s Financial Insights
  • 📈 Technical Analysis (TA) – Tevogen’s Price Targets

I'm going to help you getting a better view of Tevogen Bio Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Tevogen Bio Holdings Inc

I send you an email if I find something interesting about Tevogen Bio Holdings Inc.

1. Quick Overview

1.1. Quick analysis of Tevogen (30 sec.)










1.2. What can you expect buying and holding a share of Tevogen? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$-0.05
Expected worth in 1 year
$-0.06
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
$-0.01
Return On Investment
-1.4%

For what price can you sell your share?

Current Price per Share
$0.67
Expected price per share
$0.518 - $0.853
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Tevogen (5 min.)




Live pricePrice per Share (EOD)
$0.67
Intrinsic Value Per Share
$-1.07 - $-1.27
Total Value Per Share
$-1.12 - $-1.32

2.2. Growth of Tevogen (5 min.)




Is Tevogen growing?

Current yearPrevious yearGrowGrow %
How rich?-$9.4m-$1m-$6.4m-85.7%

How much money is Tevogen making?

Current yearPrevious yearGrowGrow %
Making money-$7.7m-$783.1k-$7m-90.0%
Net Profit Margin-653.5%0.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Tevogen (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Tevogen?

Welcome investor! Tevogen's management wants to use your money to grow the business. In return you get a share of Tevogen.

First you should know what it really means to hold a share of Tevogen. And how you can make/lose money.

Speculation

The Price per Share of Tevogen is $0.6739. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Tevogen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Tevogen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $-0.05. Based on the TTM, the Book Value Change Per Share is $0.00 per quarter. Based on the YOY, the Book Value Change Per Share is $0.10 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Tevogen.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.03-4.2%-0.04-5.9%0.00-0.6%-0.04-5.2%-0.03-4.2%-0.03-4.2%
Usd Book Value Change Per Share-0.01-1.3%0.00-0.3%0.1014.9%-0.15-21.8%0.00-0.5%0.00-0.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-1.3%0.00-0.3%0.1014.9%-0.15-21.8%0.00-0.5%0.00-0.5%
Usd Price Per Share1.25-0.93-1.12-0.68-0.55-0.55-
Price to Earnings Ratio-11.17--6.18-3.17--1.00--0.80--0.80-
Price-to-Total Gains Ratio-139.34--177.82--111.05--155.56--155.56--155.56-
Price to Book Ratio-25.92--23.87--36.44--20.10--16.08--16.08-
Price-to-Total Gains Ratio-139.34--177.82--111.05--155.56--155.56--155.56-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.6739
Number of shares1483
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.000.00
Usd Total Gains Per Share0.000.00
Gains per Quarter (1483 shares)-3.49-4.77
Gains per Year (1483 shares)-13.95-19.07
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-14-240-19-29
20-28-380-38-48
30-42-520-57-67
40-56-660-76-86
50-70-800-95-105
60-84-940-114-124
70-98-1080-133-143
80-112-1220-153-162
90-126-1360-172-181
100-140-1500-191-200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%3.09.00.025.0%4.011.00.026.7%4.011.00.026.7%4.011.00.026.7%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%6.09.00.040.0%6.09.00.040.0%6.09.00.040.0%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.015.00.0%0.00.015.00.0%0.00.015.00.0%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%6.09.00.040.0%6.09.00.040.0%6.09.00.040.0%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Tevogen Bio Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.009-0.002-74%0.101-109%-0.147+1540%-0.003-64%-0.003-64%
Book Value Per Share---0.048-0.038-21%-0.005-89%0.242-120%0.537-109%0.537-109%
Current Ratio--0.2550.302-16%0.209+22%0.376-32%1.616-84%1.616-84%
Debt To Asset Ratio--3.2222.872+12%1.925+67%3.024+7%2.428+33%2.428+33%
Debt To Equity Ratio----0%0.421-100%0.276-100%0.229-100%0.229-100%
Dividend Per Share----0%-0%-0%-0%-0%
Enterprise Value--232812684.750173036139.694+35%431102410.846-46%259058230.078-10%259058230.078-10%259058230.078-10%
Eps---0.028-0.040+42%-0.004-86%-0.035+26%-0.028+0%-0.028+0%
Ev To Ebitda Ratio---10.743-6.158-43%5.995-279%-1.297-88%-1.297-88%-1.297-88%
Free Cash Flow Per Share---0.016-0.017+5%-0.010-40%-0.011-32%-0.009-44%-0.009-44%
Free Cash Flow To Equity Per Share---0.007-0.001-91%-0.014+108%-0.004-34%0.116-106%0.116-106%
Gross Profit Margin--1.0001.0010%0.955+5%1.120-11%1.096-9%1.096-9%
Intrinsic Value_10Y_max---1.275----------
Intrinsic Value_10Y_min---1.074----------
Intrinsic Value_1Y_max---0.056----------
Intrinsic Value_1Y_min---0.055----------
Intrinsic Value_3Y_max---0.223----------
Intrinsic Value_3Y_min---0.212----------
Intrinsic Value_5Y_max---0.456----------
Intrinsic Value_5Y_min---0.419----------
Market Cap132559544.651-85%245881333.750183329122.444+34%219965441.173+12%134431521.206+83%107545216.964+129%107545216.964+129%
Net Profit Margin----6.5350%-0%-2.1780%-1.7430%-1.7430%
Operating Margin----6.5950%-0%-2.1980%-1.7590%-1.7590%
Operating Ratio---6.595-100%-0%2.198-100%1.759-100%1.759-100%
Pb Ratio-13.976+46%-25.924-23.873-8%-36.438+41%-20.104-22%-16.083-38%-16.083-38%
Pe Ratio-6.021+46%-11.168-6.182-45%3.173-452%-1.003-91%-0.803-93%-0.803-93%
Price Per Share0.674-85%1.2500.932+34%1.118+12%0.683+83%0.547+129%0.547+129%
Price To Free Cash Flow Ratio-10.390+46%-19.271-14.176-26%-24.286+26%-12.821-33%-10.257-47%-10.257-47%
Price To Total Gains Ratio-75.120+46%-139.337-177.820+28%-111.052-20%-155.564+12%-155.564+12%-155.564+12%
Quick Ratio--0.1040.147-29%0.149-30%1.553-93%1.763-94%1.763-94%
Return On Assets---1.289-1.984+54%0.058-2309%-1.069-17%-0.855-34%-0.855-34%
Return On Equity----0%-0.0990%-0.2870%-0.2300%-0.2300%
Total Gains Per Share---0.009-0.002-74%0.101-109%-0.147+1540%-0.003-64%-0.003-64%
Usd Book Value---9484742.000-7517328.000-21%-1071364.250-89%47528811.417-120%105567842.133-109%105567842.133-109%
Usd Book Value Change Per Share---0.009-0.002-74%0.101-109%-0.147+1540%-0.003-64%-0.003-64%
Usd Book Value Per Share---0.048-0.038-21%-0.005-89%0.242-120%0.537-109%0.537-109%
Usd Dividend Per Share----0%-0%-0%-0%-0%
Usd Enterprise Value--232812684.750173036139.694+35%431102410.846-46%259058230.078-10%259058230.078-10%259058230.078-10%
Usd Eps---0.028-0.040+42%-0.004-86%-0.035+26%-0.028+0%-0.028+0%
Usd Free Cash Flow---3189703.000-3337539.500+5%-1910009.500-40%-2155527.833-32%-1782606.267-44%-1782606.267-44%
Usd Free Cash Flow Per Share---0.016-0.017+5%-0.010-40%-0.011-32%-0.009-44%-0.009-44%
Usd Free Cash Flow To Equity Per Share---0.007-0.001-91%-0.014+108%-0.004-34%0.116-106%0.116-106%
Usd Market Cap132559544.651-85%245881333.750183329122.444+34%219965441.173+12%134431521.206+83%107545216.964+129%107545216.964+129%
Usd Price Per Share0.674-85%1.2500.932+34%1.118+12%0.683+83%0.547+129%0.547+129%
Usd Profit---5503979.000-7799953.750+42%-783119.750-86%-6920453.333+26%-5525450.733+0%-5525450.733+0%
Usd Revenue---99146.500-100%-0%33048.833-100%26439.067-100%26439.067-100%
Usd Total Gains Per Share---0.009-0.002-74%0.101-109%-0.147+1540%-0.003-64%-0.003-64%
 EOD+2 -6MRQTTM+17 -16YOY+9 -233Y+16 -185Y+12 -2210Y+12 -22

3.3 Fundamental Score

Let's check the fundamental score of Tevogen Bio Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-6.021
Price to Book Ratio (EOD)Between0-1-13.976
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.104
Current Ratio (MRQ)Greater than10.255
Debt to Asset Ratio (MRQ)Less than13.222
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.289
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Tevogen Bio Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.663
Ma 20Greater thanMa 500.816
Ma 50Greater thanMa 1000.897
Ma 100Greater thanMa 2001.060
OpenGreater thanClose0.760
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About Tevogen Bio Holdings Inc

Tevogen Bio Holdings Inc., a clinical-stage specialty immunotherapy company, develops off-the-shelf precision T cell therapies for the treatment of infectious diseases, cancers, and other disorders. The company develops TVGN 489, which has completed Phase 1 clinical trial for the treatment of ambulatory high-risk adult COVID-19 patients; and in phase 1 clinical trial to treat acute SARS-CoV-2 patients with B-cell cancer immune suppression, and other B cell immune suppressed acute SARS-CoV-2 patients with a B cell cancer indication, as well as Long COVID prevention and treatment. It is also developing TVGN 920 which is in preclinical trial for treating cervical cancer; TVGN 960 which is in preclinical trial for treating oropharyngeal cancer; TVGN 601 which is in preclinical trial for treating multiple sclerosis; TVGN 930 which is in preclinical trial for treating Epstein-Barr virus associated lymphomas; and TVGN 116 a product candidate targeted at hepatitis B and is in preclinical trial. Tevogen Bio Holdings Inc. was formerly known as Tevogen Bio Inc. and changed its name to Tevogen Bio Holdings Inc. in February 2024. The company was founded in 2020 and is headquartered in Warren, New Jersey.

Fundamental data was last updated by Penke on 2025-10-05 19:28:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Tevogen earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Tevogen to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Tevogen Bio Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-653.5%+653.5%
TTM-653.5%YOY--653.5%
TTM-653.5%5Y-174.3%-479.2%
5Y-174.3%10Y-174.3%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--65.5%+65.5%
TTM-653.5%-147.4%-506.1%
YOY--189.7%+189.7%
3Y-217.8%-259.0%+41.2%
5Y-174.3%-337.1%+162.8%
10Y-174.3%-472.3%+298.0%
4.3.1.2. Return on Assets

Shows how efficient Tevogen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Tevogen to the Biotechnology industry mean.
  • -128.9% Return on Assets means that Tevogen generated $-1.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Tevogen Bio Holdings Inc:

  • The MRQ is -128.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -198.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-128.9%TTM-198.4%+69.4%
TTM-198.4%YOY5.8%-204.2%
TTM-198.4%5Y-85.5%-112.8%
5Y-85.5%10Y-85.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-128.9%-11.9%-117.0%
TTM-198.4%-11.9%-186.5%
YOY5.8%-11.3%+17.1%
3Y-106.9%-12.0%-94.9%
5Y-85.5%-11.9%-73.6%
10Y-85.5%-14.0%-71.5%
4.3.1.3. Return on Equity

Shows how efficient Tevogen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Tevogen to the Biotechnology industry mean.
  • 0.0% Return on Equity means Tevogen generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Tevogen Bio Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-9.9%+9.9%
TTM-5Y-23.0%+23.0%
5Y-23.0%10Y-23.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--14.1%+14.1%
TTM--14.7%+14.7%
YOY-9.9%-15.3%+5.4%
3Y-28.7%-16.8%-11.9%
5Y-23.0%-17.4%-5.6%
10Y-23.0%-19.8%-3.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Tevogen Bio Holdings Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Tevogen is operating .

  • Measures how much profit Tevogen makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Tevogen to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Tevogen Bio Holdings Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-659.5%+659.5%
TTM-659.5%YOY--659.5%
TTM-659.5%5Y-175.9%-483.6%
5Y-175.9%10Y-175.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--148.3%+148.3%
TTM-659.5%-255.8%-403.7%
YOY--240.0%+240.0%
3Y-219.8%-245.6%+25.8%
5Y-175.9%-330.8%+154.9%
10Y-175.9%-487.4%+311.5%
4.3.2.2. Operating Ratio

Measures how efficient Tevogen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Tevogen Bio Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM6.595-6.595
TTM6.595YOY-+6.595
TTM6.5955Y1.759+4.836
5Y1.75910Y1.7590.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.853-1.853
TTM6.5952.652+3.943
YOY-2.829-2.829
3Y2.1983.550-1.352
5Y1.7594.636-2.877
10Y1.7596.253-4.494
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Tevogen Bio Holdings Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Tevogen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.25 means the company has $0.25 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Tevogen Bio Holdings Inc:

  • The MRQ is 0.255. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.302. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.255TTM0.302-0.047
TTM0.302YOY0.209+0.093
TTM0.3025Y1.616-1.314
5Y1.61610Y1.6160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2553.448-3.193
TTM0.3023.644-3.342
YOY0.2094.060-3.851
3Y0.3764.461-4.085
5Y1.6165.731-4.115
10Y1.6166.128-4.512
4.4.3.2. Quick Ratio

Measures if Tevogen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Tevogen to the Biotechnology industry mean.
  • A Quick Ratio of 0.10 means the company can pay off $0.10 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Tevogen Bio Holdings Inc:

  • The MRQ is 0.104. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.147. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.104TTM0.147-0.043
TTM0.147YOY0.149-0.002
TTM0.1475Y1.763-1.616
5Y1.76310Y1.7630.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1042.764-2.660
TTM0.1473.124-2.977
YOY0.1493.845-3.696
3Y1.5534.322-2.769
5Y1.7635.680-3.917
10Y1.7636.522-4.759
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Tevogen Bio Holdings Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Tevogen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Tevogen to Biotechnology industry mean.
  • A Debt to Asset Ratio of 3.22 means that Tevogen assets are financed with 322.2% credit (debt) and the remaining percentage (100% - 322.2%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Tevogen Bio Holdings Inc:

  • The MRQ is 3.222. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 2.872. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ3.222TTM2.872+0.350
TTM2.872YOY1.925+0.947
TTM2.8725Y2.428+0.444
5Y2.42810Y2.4280.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ3.2220.341+2.881
TTM2.8720.361+2.511
YOY1.9250.331+1.594
3Y3.0240.343+2.681
5Y2.4280.350+2.078
10Y2.4280.381+2.047
4.5.4.2. Debt to Equity Ratio

Measures if Tevogen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Tevogen to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Tevogen Bio Holdings Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY0.421-0.421
TTM-5Y0.229-0.229
5Y0.22910Y0.2290.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.395-0.395
TTM-0.438-0.438
YOY0.4210.432-0.011
3Y0.2760.471-0.195
5Y0.2290.467-0.238
10Y0.2290.518-0.289
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Tevogen generates.

  • Above 15 is considered overpriced but always compare Tevogen to the Biotechnology industry mean.
  • A PE ratio of -11.17 means the investor is paying $-11.17 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Tevogen Bio Holdings Inc:

  • The EOD is -6.021. Based on the earnings, the company is expensive. -2
  • The MRQ is -11.168. Based on the earnings, the company is expensive. -2
  • The TTM is -6.182. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-6.021MRQ-11.168+5.147
MRQ-11.168TTM-6.182-4.986
TTM-6.182YOY3.173-9.355
TTM-6.1825Y-0.803-5.380
5Y-0.80310Y-0.8030.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-6.021-2.738-3.283
MRQ-11.168-2.296-8.872
TTM-6.182-2.657-3.525
YOY3.173-3.631+6.804
3Y-1.003-3.737+2.734
5Y-0.803-5.974+5.171
10Y-0.803-6.848+6.045
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Tevogen Bio Holdings Inc:

  • The EOD is -10.390. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -19.271. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -14.176. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-10.390MRQ-19.271+8.882
MRQ-19.271TTM-14.176-5.096
TTM-14.176YOY-24.286+10.111
TTM-14.1765Y-10.257-3.919
5Y-10.25710Y-10.2570.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-10.390-3.422-6.968
MRQ-19.271-2.906-16.365
TTM-14.176-3.631-10.545
YOY-24.286-4.296-19.990
3Y-12.821-5.238-7.583
5Y-10.257-8.367-1.890
10Y-10.257-9.706-0.551
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Tevogen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -25.92 means the investor is paying $-25.92 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Tevogen Bio Holdings Inc:

  • The EOD is -13.976. Based on the equity, the company is expensive. -2
  • The MRQ is -25.924. Based on the equity, the company is expensive. -2
  • The TTM is -23.873. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-13.976MRQ-25.924+11.948
MRQ-25.924TTM-23.873-2.051
TTM-23.873YOY-36.438+12.565
TTM-23.8735Y-16.083-7.790
5Y-16.08310Y-16.0830.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-13.9762.488-16.464
MRQ-25.9242.047-27.971
TTM-23.8732.204-26.077
YOY-36.4382.464-38.902
3Y-20.1042.632-22.736
5Y-16.0833.755-19.838
10Y-16.0834.450-20.533
4.6.2. Total Gains per Share

2.4. Latest News of Tevogen Bio Holdings Inc

Does Tevogen Bio Holdings Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Tevogen Bio Holdings Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-19
21:40
Tevogen Commends HHS for Addressing Long COVID, Emphasizes TVGN 489’s Potential Impact for 20 Million AmericansRead

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Tevogen Bio Holdings Inc.

4.8.3. Insider Transactions

Insiders are holding 79.36% of the shares of Tevogen Bio Holdings Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2025-06-09Ryan H SaadiSELL14382061.23
2025-03-12Neal FlomenbergSELL2329681.09
2025-03-10Neal FlomenbergSELL703841.09
2025-03-06Neal FlomenbergSELL885191.1
2025-03-04Neal FlomenbergSELL146391.28
2024-10-17Neal FlomenbergSELL10786001.62
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets4,269
Total Liabilities13,754
Total Stockholder Equity-9,485
 As reported
Total Liabilities 13,754
Total Stockholder Equity+ -9,485
Total Assets = 4,269

Assets

Total Assets4,269
Total Current Assets2,061
Long-term Assets2,208
Total Current Assets
Cash And Cash Equivalents 685
Net Receivables 159
Other Current Assets 1,217
Total Current Assets  (as reported)2,061
Total Current Assets  (calculated)2,061
+/-0
Long-term Assets
Property Plant Equipment 1,642
Long-term Assets Other 566
Long-term Assets  (as reported)2,208
Long-term Assets  (calculated)2,208
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities8,082
Long-term Liabilities5,672
Total Stockholder Equity-9,485
Total Current Liabilities
Short-term Debt 1,979
Short Long Term Debt 1,651
Accounts payable 4,240
Other Current Liabilities 1,863
Total Current Liabilities  (as reported)8,082
Total Current Liabilities  (calculated)9,733
+/- 1,651
Long-term Liabilities
Long term Debt 4,400
Capital Lease Obligations 1,505
Long-term Liabilities  (as reported)5,672
Long-term Liabilities  (calculated)5,905
+/- 233
Total Stockholder Equity
Common Stock19
Retained Earnings -129,256
Other Stockholders Equity 110,952
Total Stockholder Equity (as reported)-9,485
Total Stockholder Equity (calculated)-18,285
+/- 8,800
Other
Capital Stock8,819
Cash and Short Term Investments 685
Common Stock Shares Outstanding 184,307
Liabilities and Stockholders Equity 4,269
Net Debt 6,871
Net Invested Capital -12,234
Net Working Capital -6,021
Property Plant and Equipment Gross 1,642
Short Long Term Debt Total 7,556



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-30
> Total Assets 
0
167
352,852
352,830
352,979
354,542
357,138
25,470
5,638
26,410
17,037
3,363
3,310
4,289
3,462
4,073
4,269
4,2694,0733,4624,2893,3103,36317,03726,4105,63825,470357,138354,542352,979352,830352,8521670
   > Total Current Assets 
0
0
791
734
595
418
274
97
3,665
399
356
2,400
2,447
3,528
2,361
3,078
2,061
2,0613,0782,3613,5282,4472,4003563993,6659727441859573479100
       Cash And Cash Equivalents 
0
0
345
232
186
143
129
52
3,457
348
9
1,318
1,135
2,331
1,283
1,975
685
6851,9751,2832,3311,1351,31893483,4575212914318623234500
       Short-term Investments 
0
0
0
0
0
0
0
10,969
0
0
0
0
0
0
0
0
0
00000000010,9690000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
345
159
159
159
0
159
159
15915901591591593450000000000
       Other Current Assets 
0
0
447
503
409
275
145
45
209
157
3
923
1,153
1,038
919
944
1,217
1,2179449191,0381,15392331572094514527540950344700
   > Long-term Assets 
0
167
352,061
352,096
352,385
354,124
356,864
25,373
1,973
26,010
16,681
963
863
762
1,101
995
2,208
2,2089951,10176286396316,68126,0101,97325,373356,864354,124352,385352,096352,0611670
       Property Plant Equipment 
0
0
0
0
0
0
1,307
0
1,123
1,029
929
830
730
628
525
420
1,642
1,6424205256287308309291,0291,12301,307000000
> Total Liabilities 
0
153
15,180
15,183
15,126
15,076
15,058
15,425
92,530
16,563
17,733
9,166
10,944
10,480
10,136
11,793
13,754
13,75411,79310,13610,48010,9449,16617,73316,56392,53015,42515,05815,07615,12615,18315,1801530
   > Total Current Liabilities 
0
153
59
179
259
282
350
667
64,918
1,827
3,004
8,938
10,612
10,416
9,043
8,720
8,082
8,0828,7209,04310,41610,6128,9383,0041,82764,918667350282259179591530
       Short-term Debt 
0
82
0
0
0
0
278
0
63,221
916
1,884
1,912
2,188
2,922
0
1,822
1,979
1,9791,82202,9222,1881,9121,88491663,22102780000820
       Short Long Term Debt 
0
0
0
0
0
0
0
0
62,931
0
1,632
1,651
1,651
2,663
1,651
1,651
1,651
1,6511,6511,6512,6631,6511,6511,632062,93100000000
       Accounts payable 
0
0
0
0
0
0
210
0
1,106
1,886
1,142
5,212
6,666
5,838
5,200
4,665
4,240
4,2404,6655,2005,8386,6665,2121,1421,8861,1060210000000
       Other Current Liabilities 
0
72
59
179
259
282
-138
667
592
-975
-23
1,815
2,007
1,905
403
2,233
1,863
1,8632,2334031,9052,0071,815-23-975592667-13828225917959720
   > Long-term Liabilities 
0
0
15,121
15,005
14,867
14,794
14,707
14,758
27,611
14,736
14,729
228
332
64
1,093
3,073
5,672
5,6723,0731,0936433222814,72914,73627,61114,75814,70714,79414,86715,00515,12100
> Total Stockholder Equity
0
14
337,672
337,646
337,853
339,466
342,081
10,045
-86,892
9,847
-696
-5,803
-7,634
-6,190
-6,674
-7,720
-9,485
-9,485-7,720-6,674-6,190-7,634-5,803-6969,847-86,89210,045342,081339,466337,853337,646337,672140
   Common Stock
0
1
351,901
351,901
351,901
354,125
356,865
25,375
62
26,012
16,683
16
17
17
0
18
19
1918017171616,68326,0126225,375356,865354,125351,901351,901351,90110
   Retained Earnings Total Equity00000000000000000
   Accumulated Other Comprehensive Income 0000-2,8000000-33,9510000000
   Capital Surplus 00000000000000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
24
0
0
0
0
0
25,375
5,167
0
0
76,161
87,606
90,933
0
107,214
110,952
110,952107,214090,93387,60676,161005,16725,37500000240



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2025-06-30. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue0
Cost of Revenue-404
Gross Profit-404-404
 
Operating Income (+$)
Gross Profit-404
Operating Expense-53,161
Operating Income-53,564-53,564
 
Operating Expense (+$)
Research Development31,033
Selling General Administrative22,531
Selling And Marketing Expenses0
Operating Expense53,16153,564
 
Net Interest Income (+$)
Interest Income0
Interest Expense-184
Other Finance Cost-0
Net Interest Income-184
 
Pretax Income (+$)
Operating Income-53,564
Net Interest Income-184
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-14-93,402
EBIT - interestExpense = -13,727
-13,727
-13,543
Interest Expense184
Earnings Before Interest and Taxes (EBIT)-13,543170
Earnings Before Interest and Taxes (EBITDA)-13,140
 
After tax Income (+$)
Income Before Tax-14
Tax Provision-0
Net Income From Continuing Ops-13,727-14
Net Income-13,727
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses54
Total Other Income/Expenses Net39,837184
 

Technical Analysis of Tevogen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Tevogen. The general trend of Tevogen is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Tevogen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Tevogen Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Tevogen Bio Holdings Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.7524 < 0.83 < 0.853.

The bearish price targets are: 0.74 > 0.74 > 0.518.

Know someone who trades $TVGN? Share this with them.👇

Tevogen Bio Holdings Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Tevogen Bio Holdings Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Tevogen Bio Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Tevogen Bio Holdings Inc. The current macd is -0.0466129.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tevogen price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Tevogen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Tevogen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Tevogen Bio Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartTevogen Bio Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Tevogen Bio Holdings Inc. The current adx is 14.78.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Tevogen shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Tevogen Bio Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Tevogen Bio Holdings Inc. The current sar is 0.869368.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Tevogen Bio Holdings Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Tevogen Bio Holdings Inc. The current rsi is 26.66. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
Tevogen Bio Holdings Inc Daily Relative Strength Index (RSI) ChartTevogen Bio Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Tevogen Bio Holdings Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Tevogen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Tevogen Bio Holdings Inc Daily Stochastic Oscillator ChartTevogen Bio Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Tevogen Bio Holdings Inc. The current cci is -196.59352343.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Tevogen Bio Holdings Inc Daily Commodity Channel Index (CCI) ChartTevogen Bio Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Tevogen Bio Holdings Inc. The current cmo is -55.34580487.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Tevogen Bio Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartTevogen Bio Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Tevogen Bio Holdings Inc. The current willr is -89.74126192.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Tevogen Bio Holdings Inc Daily Williams %R ChartTevogen Bio Holdings Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Tevogen Bio Holdings Inc.

Tevogen Bio Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Tevogen Bio Holdings Inc. The current atr is 0.05557513.

Tevogen Bio Holdings Inc Daily Average True Range (ATR) ChartTevogen Bio Holdings Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Tevogen Bio Holdings Inc. The current obv is 946,649,344.

Tevogen Bio Holdings Inc Daily On-Balance Volume (OBV) ChartTevogen Bio Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Tevogen Bio Holdings Inc. The current mfi is 31.95.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Tevogen Bio Holdings Inc Daily Money Flow Index (MFI) ChartTevogen Bio Holdings Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Tevogen Bio Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-16MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-19MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-05-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-05-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-05-23STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-05-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-29WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-05-30STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-06-04STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-06STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
RSI SHORT ENTRY LONG CLOSE70 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-06-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-17STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-20CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-23DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2025-06-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-16CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-17MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2025-07-18SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-07-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-30DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2025-07-31STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-05DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-08-06SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-07BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-08-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-11RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2025-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-08-14STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-08-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-22STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-28WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-04STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-08STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-11STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-16STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-17STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2025-09-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-09-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-09-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-09-26STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-09-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-10-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2025-10-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

Tevogen Bio Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Tevogen Bio Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5026.663
Ma 20Greater thanMa 500.816
Ma 50Greater thanMa 1000.897
Ma 100Greater thanMa 2001.060
OpenGreater thanClose0.760
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Tevogen with someone you think should read this too:
  • Are you bullish or bearish on Tevogen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Tevogen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Tevogen Bio Holdings Inc

I send you an email if I find something interesting about Tevogen Bio Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Tevogen Bio Holdings Inc.

Receive notifications about Tevogen Bio Holdings Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.